Sesi CME: "Novel Irreversible EGFR TKI for the treatment of EGFR Mutation positive NSCLC & Trial data presentation"
Tarikh : 8 Jun 2016 (Rabu)
Masa : 1.00 pm - 2.00 pm
Tempat : Bilik Mesyuarat Delima, BPF
Penceramah : Dato' Dr. Mohamed Ibrahim
(Consultant Clinical Oncologist, Beacon Hospital)
Tajaan : Boehringer-ingelheim
Mata CPD : A4 (1 mata/topik)
No comments:
Post a Comment